Role of cytokine gene polymorphism in recurrent HCV infection after liver transplantation

被引：7
|
作者：
Ben-Ari, Ziv
机构：
[1] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 11期
关键词：
D O I：
10.1002/lt.20844
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1723 / 1724
页数：2
相关论文
共 50 条
  • [41] Hepatitis C virus (HCV)-specific CD8+T cells in patients with recurrent HCV-infection after liver transplantation (OLTx)
    Schirren, CA
    Gruener, NH
    Jung, MC
    Zachoval, R
    Gerlach, JT
    Diepolder, H
    Houghton, M
    Rau, HG
    Pape, GR
    JOURNAL OF HEPATOLOGY, 2001, 34 : 115 - 115
  • [42] Cytokine gene polymorphism in recurrent acute otitis media
    Joki-Erkkilä, VP
    Puhakka, H
    Hurme, M
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (01) : 17 - 20
  • [43] The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
    Guel-Klein, Safak
    Schmitz, Paulina
    Schoning, Wenzel
    Oelinger, Robert
    Lurje, Georg
    Jonas, Sven
    Uluk, Deniz
    Pelzer, Uwe
    Tacke, Frank
    Schmelzle, Moritz
    Pratschke, Johann
    Ossami Saidy, Ramin Raul
    Eurich, Dennis
    CANCERS, 2022, 14 (12)
  • [44] Cytokine gene polymorphism in liver allograft recipients
    Mor, E
    Klein, T
    Shabtai, E
    Ben-Ari, Z
    Ortegel, JW
    Micowitz, R
    Tur-Kaspa, R
    Tambur, AR
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (06) : 2941 - 2942
  • [45] HCV infection and posttransplant lymphoproliferative disorders (PTLD) after liver transplantation (LT).
    Hézode, C
    Duvoux, C
    Germanidis, G
    Roudot-Thoraval, F
    Cherqui, D
    Pawlotsky, JM
    Dhumeaux, D
    HEPATOLOGY, 1998, 28 (04) : 260A - 260A
  • [46] Combination therapy produces disappointing responses in the treatment of recurrent HCV after liver transplantation
    Ross, A
    Terella, A
    Cosimi, AB
    Chung, RT
    GASTROENTEROLOGY, 2002, 123 (01) : 73 - 73
  • [47] Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection after Liver Transplantation
    Curry, Michael P.
    Forns, Xavier
    Chung, Raymond T.
    Terrault, Norah
    Brown, Robert S.
    Fenkel, Jonathan M.
    Gordon, Fredric D.
    O'Leary, Jacqueline G.
    Kuo, Alexander
    Schiano, Thomas D.
    Everson, Gregory T.
    Schiff, Eugene R.
    Befeler, Alex
    McHutchison, John G.
    Symonds, William T.
    Denning, Jill M.
    McNair, Lindsay
    Arterburn, Sarah
    Moonka, Dilip
    Gane, Edward J.
    Afdhal, Nezam H.
    HEPATOLOGY, 2013, 58 : 314A - 315A
  • [48] Determinants of hepatitis C virus (HCV) infection after liver transplantation (LT)
    Everhart, JE
    HEPATOLOGY, 1998, 28 (04) : 349A - 349A
  • [49] NEW ERA OF ANTIVIRAL TREATMENT OF HCV-INFECTION AFTER LIVER TRANSPLANTATION
    Yaroshenko, Ekaterina
    Kornilov, Maxim
    Gichkun, Olga
    TRANSPLANT INTERNATIONAL, 2015, 28 : 371 - 371
  • [50] An open trial of ribavirin in chronic HCV infection after liver transplantation.
    Feray, C
    Roche, B
    Dussaix, E
    Gigou, M
    Aulong, B
    Reynes, M
    Samuel, D
    Bismuth, H
    HEPATOLOGY, 1997, 26 (04) : 114 - 114
12345